/Investor DB

UTokyo Innovation Platform Co. Ltd. — 2026 Investments

1 investments dated 2026 · listed companies and verified rows first · show all

Storm Therapeuticsstormtherapeutics.comin𝕏Apr 2026 · $56M

STORM Therapeutics is a clinical-stage biotechnology company developing small molecule drugs that target RNA modifying enzymes to reprogram cells through RNA biology.

BiotechHealthtechMedical DevicesWaterbeach, Cambridgeshire, GB

Jerry McMahon, PhD(Chief Executive Officer & President)Professor Tony Kouzarides, PhD, FMedSci, FRS(Director & Founder)

Co-investorsCambridge Innovation CapitalFast Track InitiativeM VenturesPfizer Venture InvestmentsSeroba Life SciencesTaiho Ventures, LLC+3 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.